The system effectively expands tumor-infiltrating lymphocytes, resulting in a 6.62-fold increase in CD4+ T cells compared to controls, along with elevated populations of CD8+ T cells and Granzyme B+ cytotoxic cells, as well as enhanced pro-inflammatory cytokine expression. The gene discussed is GZMB; the disease is neoplasm.